Answers are grounded in this paper and cite their sources.
The prevalence of headache was higher in patients with mitochondrial diseases than reported in the general population. In all phenotype and genotype groups, TTH was more frequent than migraine. The data also show that the current ICHD-3 beta exclusively focused on MELAS syndrome as vasculopathy does not consider the broader spectrum of headache phenotypes in mitochondrial disorders.
No takes yet. Share an insight, caveat, or question.
Kraya et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: